Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN")
Relevance. Interpretation of the preclinical trials data is fundamental importance. The correctness of extrapolation of data obtained from animals to humans is due to the qualitative and quantitative diversity of the systems tested the recorded parameters and approaches to their interpretation, as w...
Saved in:
Main Authors: | V. B. Vasilyuk (Author), M. V. Faraponova (Author), G. I. Syraeva (Author), A. B. Verveda (Author), A. V. Belskaya (Author), A. V. Shults (Author), L. G. Kubarskaya (Author), E. A. Zolotoverkhaya (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters
by: V. B. Vasilyuk, et al.
Published: (2024) -
Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024) -
Toxic reactions of non-steroidal anti-inflammatory drugs in the Russian Federation, analysis of the national database "Pharmacovigilance"
by: G. I. Syraeva, et al.
Published: (2023) -
Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia
by: G. G. Rodionov, et al.
Published: (2021) -
IVFarma LLC in cooperation with Zavod Medsintez LLC extend production of biotechnological drugs for infertility treatment
by: article Editorial
Published: (2023)